A Study to Evaluate the Safety and Efficacy of AK120 in Subjects With Moderate to Severe Atopic Dermatitis
Clinical trial NCT06092762 · COMPLETED
Trial details
- NCT number
- NCT06092762
- Sponsor
- Akeso
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-06
- Primary completion
- 2024-11-13
- Enrollment
- 180
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.